Bright Green Announces Third Quarter 2023 Financial Update and Milestone Progress
Bright Green has achieved several key milestones throughout the Quarter advancing progress against its strategic plan. Continued marketing of its...
Month: November 2023
Annexon Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference
BRISBANE, Calif., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class...
Thornhill Medical Ramps Up Production of MADM™, its Mobile Gas Anesthesia Technology Built for Extreme Conditions
Thornhill Medical's Mobile Anesthesia Delivery Module (MADM™) Thornhill Medical Ramps Up Production of MADM™, its Mobile Gas Anesthesia Technology Built...
bioLytical Laboratories Inc. Donates Tests to Help Boost International Testing Access Ahead of International Testing Week
bioLytical Laboratories Inc., in partnership with NGO Coalition Plus, Leads the Charge to Promote the Importance of Rapid Testing during...
Safety Shot issues warning to its shareholders.
JUPITER, FL, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) it has come to our attention that...
Bavarian Nordic to hold Capital Markets Days in February 2024
COPENHAGEN, Denmark, November 22, 2023 – Bavarian Nordic A/S (OMX: BAVA) will hold a series of capital markets days in...
EssilorLuxottica and Moncler announce an exclusive licensing agreement
ESSILORLUXOTTICA AND MONCLER ANNOUNCE AN EXCLUSIVE LICENSING AGREEMENT Charenton-le-Pont, France and Milan, Italy (November 22, 2023 – 6:00 pm CET)...
ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
BAUDETTE, Minn., Nov. 22, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that...
Immix Biopharma to Host KOL Event to Discuss its BCMA-Targeted CAR-T Cell Therapy Candidate NXC-201 for Relapsed/Refractory AL Amyloidosis
Virtual Event to be held on November 29, 2023 at 4:15 p.m. ETLOS ANGELES, Nov. 22, 2023 (GLOBE NEWSWIRE) --...
Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
YARDLEY, Pa., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose...
Scilex Holding Company Announces Market Research Results with Neurologists, Headache Specialists, and Primary Care Physicians Demonstrating Potential High Unmet Needs In Treating Acute Migraine Targeted By ELYXYB® with Potential Advantages Compared to Calcitonin Gene-Related Peptide (CGRP) Products and Triptan Therapy
Exhibit A Exhibit A Exhibit B Exhibit B Exhibit C Exhibit C Migraines affect over 37 million Americans, according to...
Last Day of the Subscription Period in Spago Nanomedical’s Rights Issue
NOT INTENDED FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG-KONG, JAPAN, CANADA, SWITZERLAND,...
PaxMedica Announces Closing of $7.0 Million Public Offering
TARRYTOWN, NY / ACCESSWIRE / November 22, 2023 / PaxMedica, Inc. (NASDAQ:PXMD) ("PaxMedica" or the "Company"), a biopharmaceutical company focused...
Microline Surgical Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Retraction Limited
BEVERLY, Mass.--(BUSINESS WIRE)--Microline Surgical, Inc. (“Microline” or the “Company”), a subsidiary of HOYA Corporation, today announced that it has acquired...
CNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Safety Data from Ongoing Potentially Pivotal Study Evaluating Berubicin in Advance of the Pre-Planned Interim Analysis of Efficacy
Data presented at the Society of NeuroOncology (SNO) 28th Annual MeetingBerubicin currently being evaluated in an ongoing potentially pivotal study...
Agape ATP Corporation Announces US$1 Million Share Repurchase Plan
KUALA LUMPUR, MALAYSIA / ACCESSWIRE / November 22, 2023 / AGAPE ATP Corporation (NASDAQ:ATPC) ("ATPC" or the "Company") announced that...
Wave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI HealthCONx Conference
CAMBRIDGE, Mass., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed...
Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference
MINNEAPOLIS, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies...
Alladapt Immunotherapeutics Receives FDA Fast Track Designation for ADP101 for the Treatment of Mono- and Multi-Food Allergies
– Fast Track Designation accelerates ADP101's development path for the treatment of mono- and multi-food allergy – – Phase 1/2...
Solid Biosciences to Participate at 35th Annual Piper Sandler Healthcare Conference
CHARLESTOWN, Mass., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines...